Skip to main content
. 2022 Jul 14;11(14):4082. doi: 10.3390/jcm11144082

Table 1.

Patient characteristics and comorbidities.

PWIDs n (%) Non-PWIDs n (%) Total n (%)
Sex
 Male 48 (78.69) 444 (27.92) 492 (27.33)
 Female 13 (21.31) 172 (72.08) 185 (72.67)
Age Class (years)
 <40 28 (45.9) 52 (8.44) 80 (11.82)
 41–50 31 (50.82) 61 (9.9) 92 (13.59)
 51–60 2 (3.28) 93 (15.1) 95 (14.03)
 61–70 0 157 (25.49) 157 (23.19)
 71–80 0 193 (31.33) 193 (28.51)
 >80 0 60 (9.74) 60 (8.86)
Ongoing IDU 61 (100) 0 61 (9.01)
History of IDU 61 (100) 22 (3.75) 83 (12.26)
Comorbidities
 Cancer 1 (1.64) 65 (10.55) 66 (9.75)
 COPD 1 (1.64) 64 (10.39) 65 (9.6)
 History of acute myocardial infarction 0 47 (7.63) 47 (6.94)
 Ischemic heart diseases 1 (1.64) 94 (15.26) 95 (14.03)
 Hypertension 1 (1.64) 256 (41.56) 257 (37.96)
 Renal failure 4 (6.56) 81 (13.15) 85 (12.56)
 Alcoholism 1 (1.64) 21 (3.41) 22 (3.25)
 Peripheral arterial disease 1 (1.64) 46 (7.47) 47 (6.94)
 Chronic liver disease 20 (32.79) 44 (7.14) 64 (9.45)
 Peptic ulcer 1 (1.64) 17 (2.76) 18 (2.66)
 Neurologic vascular diseases 0 35(5.68) 35(5.17)
 Stroke 0 29(4.71) 29 (4.28)
 HIV-positive 21(34,42) 19 (3.06) 40 (5.8)
 AIDS 9 (14.75) 7(1.1) 16 (2.3%)
Procedures
 Dental 1 (1.64) 31 (5.03) 32 (4.73)
 Intravenous catheter 6 (9.84) 152 (24.68) 158 (23.34)
 Other invasive procedures 4 (6.56) 135 (21.75) 149 (22.01)

Abbreviations: IDU: intravenous drug use; PWID: people who inject drugs; COPD: chronic obstructive pulmonary disease; AIDS: acquired immunodeficiency syndrome; HIV: human immunodeficiency virus.